[1]
2024. SGLT2 Inhibitors vs. Finerenone for Slowing CKD Progression in Hypertensive Diabetic Patients with Obesity: A Comparative Effectiveness Study. Journal of AI-Powered Medical Innovations (International online ISSN 3078-1930). 2, 1 (Oct. 2024), 21–236. DOI:https://doi.org/10.60087/Japmi.Vol.02.Issue.01.Id.016.